These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6177758)

  • 1. The effect of target cell differentiation on human natural killer cell activity: a specific defect in target cell binding and early activation events.
    Werkmeister JA; Helfand SL; Haliotis T; Pross HF; Roder JC
    J Immunol; 1982 Jul; 129(1):413-8. PubMed ID: 6177758
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytostatic activity of granulocytes in patients with acute leukemia].
    Vartanian NL; Luganova IS; Blinov MN
    Eksp Onkol; 1988; 10(1):49-52. PubMed ID: 3163545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between fresh human blood monocytes and tumor targets at the single cell level: binding and morphological characteristics.
    Muse KE; Koren HS
    J Reticuloendothel Soc; 1982 Nov; 32(5):323-37. PubMed ID: 6962303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer (NK) activity of normal human peripheral blood lymphocytes against erythroleukemic cell line K 562.
    Tanaka Y
    Hiroshima J Med Sci; 1981 Jun; 30(2):115-26. PubMed ID: 6946049
    [No Abstract]   [Full Text] [Related]  

  • 8. [Decrease of insulin binding to human acute leukemic cells during chemically induced differentiation].
    Palumbo A; Turco GL; Brossa C; D'Alberto M; Ghezzo F; Pegoraro L
    Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1350-4. PubMed ID: 7004463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing.
    Salata RA; Kleinhenz ME; Schacter BZ; Ellner JJ
    Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory control of the proliferation ad differentiation of normal and leukemia cells.
    Metcalf D
    Natl Cancer Inst Monogr; 1982; 60():123-31. PubMed ID: 6981771
    [No Abstract]   [Full Text] [Related]  

  • 12. From mice to human: the "two-hit model" of leukemogenesis.
    Kosmider O; Moreau-Gachelin F
    Cell Cycle; 2006 Mar; 5(6):569-70. PubMed ID: 16582609
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased natural killer cell activity in children with untreated acute leukemia.
    Nasrallah AG; Miale TD
    Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of membrane changes, differentiation, and malignancy in carcinogenesis.
    Sachs L
    Harvey Lect; 1974; 68():1-35. PubMed ID: 4375672
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of an oxidation-resistant tumor cell line and its sensitivity to immune response and chemotherapy.
    Sauri H; Kim AT; Shau H
    J Surg Res; 1995 May; 58(5):526-35. PubMed ID: 7745966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of natural killer-like cytotoxicity from human thymocytes with interleukin-2.
    Gray JD; Torten M; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):124-33. PubMed ID: 6209571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
    Hagner G
    Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human NK cell cytotoxicity against K562 cells with glycopeptides from K562 plasma membranes.
    Decker JM; Hinson A; Ades EW
    J Clin Lab Immunol; 1984 Nov; 15(3):137-43. PubMed ID: 6397595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E; Savary CA; Stringfellow DA
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon activation of latent natural killer cells and alteration in kinetics of target cell lysis: clinical implications for oral precancerous lesions.
    Pillai MR; Balaram P; Kannan S; Sudha L; Nalinakumari KR; Hareendran NK; Nair MK
    Oral Surg Oral Med Oral Pathol; 1990 Oct; 70(4):458-61. PubMed ID: 1699193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.